1. Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain
2. Miguel Servet Ophthalmology Research Group (GIMSO), Aragon Health Research Institute (IIS Aragon), Zaragoza, Spain
3. National Ocular Pathology Network (OFTARED), Carlos III Health Institute, Madrid, Spain
4. Complutense University of Madrid. Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Spain
5. Health Research Institute, San Carlos Clinical Hospital (IdISSC), Madrid, Spain
6. Miguel Servet Ophthalmology Research Group (GIMSO), University of Zaragoza, Aragon Health Research Institute (IIS Aragon), Zaragoza, Spain
7. Department of Pathology, Lozano Blesa University Hospital, Zaragoza, Spain
8. Complutense University of Madrid. Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415. National Ocular Pathology Network (OFTARED), Carlos III Health Institute, Spain
9. Servicio de Oftalmología, Hospital Clínico San Carlos, Madrid, Spain
10. Departamento de Inmunología, Oftalmología y ORL, Facultad de Medicina, Universidad Complutense de Madrid (UCM), IdISSC, Madrid, Spain
11. Animal Biotechnology and Gene Therapy Centre (CBATEG), Universitat Autònoma de Barcelona, Bellaterra, Spain
12. Networked Biomedical Research Centre for Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid, Spain
13. Department of Animal Health and Anatomy, School of Veterinary Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain